Patients with idiopathic pulmonary fibrosis-associated chronic cough who received twice-daily oral extended release ...
Angiotensin-converting enzyme (ACE) inhibitors were found to be independently associated with reducing all-cause mortality in ...
IPF-associated cough affects up to 80% of patients with IPF, substantially impairing their quality of life; consequently, ...
Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results